Oncoprotein BMI‐1 induces the malignant transformation of HaCaT cells
Oncoprotein BMI‐1 induces the malignant transformation of HaCaT cells
复制标题
DOI:
10.1002/jcb.21969
复制
发表时间:
2009
影响因子:
4
通讯作者:
Qian Wang;Wen-lin Li;Pu You;Juan Su;Ming-hua Zhu;D. Xie;Haiying Zhu;Zhiying He;Jianxiu Li;Xiaoyan Ding;Xin Wang;Yi-Ping Hu
中科院分区:
文献类型:
--
作者:
Qian Wang;Wen-lin Li;Pu You;Juan Su;Ming-hua Zhu;D. Xie;Haiying Zhu;Zhiying He;Jianxiu Li;Xiaoyan Ding;Xin Wang;Yi-Ping Hu
BMI‐1 (B‐cell‐specific Moloney murine leukemia virus integration site 1), a novel oncogene, has attracted much attention in recent years for its involvement in the initiation of a variety of tumors. Recent evidence showed that BMI‐1 was highly expressed in neoplastic skin lesions. However, whether dysregulated BMI‐1 expression is causal for the transformation of skin cells remains unknown. In this study, we stably expressed BMI‐1 in a human keratinocyte cell line, HaCaT. The expression of wild‐type BMI‐1 induced the malignant transformation of HaCaT cells in vitro. More importantly, we found that expression of BMI‐1 promoted formation of squamous cell carcinomas in vivo. Furthermore, we showed that BMI‐1 expression led to the downregulation of tumore suppressors, such as p16INK4a and p14ARF, cell adhesion molecules, such as E‐Cadherin, and differentiation related factor, such as KRT6. Therefore, our findings demonstrated that dysregulated BMI‐1 could indeed lead to keratinocytes transformation and tumorigenesis, potentially through promoting cell cycle progression and increasing cell mobility. J. Cell. Biochem. 106: 16–24, 2009. © 2008 Wiley‐Liss, Inc.